These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
707 related articles for article (PubMed ID: 9090763)
1. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy. Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763 [TBL] [Abstract][Full Text] [Related]
2. Is bone turnover a determinant of bone mass in rheumatoid arthritis? Cortet B; Flipo RM; Pigny P; Duquesnoy B; Boersma A; Marchandise X; Delcambre B J Rheumatol; 1998 Dec; 25(12):2339-44. PubMed ID: 9858427 [TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis. Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038 [TBL] [Abstract][Full Text] [Related]
4. Bone marker alterations in patients with type 1 Gaucher disease. Ciana G; Martini C; Leopaldi A; Tamaro G; Katouzian F; Ronfani L; Bembi B Calcif Tissue Int; 2003 Mar; 72(3):185-9. PubMed ID: 12522660 [TBL] [Abstract][Full Text] [Related]
5. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538 [TBL] [Abstract][Full Text] [Related]
6. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer. Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784 [TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer. Tähtelä R; Thölix E Anticancer Res; 1996; 16(4B):2289-93. PubMed ID: 8694558 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy. Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926 [TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]. Forsblad d'Elia H; Christgau S; Mattsson LA; Saxne T; Ohlsson C; Nordborg E; Carlsten H Arthritis Res Ther; 2004; 6(5):R457-68. PubMed ID: 15380045 [TBL] [Abstract][Full Text] [Related]
10. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468 [TBL] [Abstract][Full Text] [Related]
11. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488 [TBL] [Abstract][Full Text] [Related]
12. Telopeptides as markers of bone turnover in rheumatoid arthritis and osteoarthritis. Wong PK; Young L; Vaile JH; Tan L; Bertouch JV; Bleasel JF; White C Intern Med J; 2004; 34(9-10):539-44. PubMed ID: 15482266 [TBL] [Abstract][Full Text] [Related]
13. Intestinal calcium absorption and bone metabolism in young adult men with childhood-onset growth hormone deficiency. de Boer H; Blok GJ; Popp-Snijders C; Sips A; Lips P; van der Veen E J Bone Miner Res; 1998 Feb; 13(2):245-52. PubMed ID: 9495517 [TBL] [Abstract][Full Text] [Related]
15. Effect of age-related chronic immobility on markers of bone turnover. Chen JS; Cameron ID; Cumming RG; Lord SR; March LM; Sambrook PN; Simpson JM; Seibel MJ J Bone Miner Res; 2006 Feb; 21(2):324-31. PubMed ID: 16418789 [TBL] [Abstract][Full Text] [Related]
16. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP]. Kobayashi Y; Ochi M; Tokue A Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802 [TBL] [Abstract][Full Text] [Related]
17. Biochemical picture of bone metabolism in breast cancer patients with bone metastases. Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881 [TBL] [Abstract][Full Text] [Related]
18. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial. Pullerits R; d'Elia HF; Tarkowski A; Carlsten H Rheumatology (Oxford); 2009 Jul; 48(7):785-90. PubMed ID: 19416946 [TBL] [Abstract][Full Text] [Related]
19. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women. Akesson K; Ljunghall S; Jonsson B; Sernbo I; Johnell O; Gärdsell P; Obrant KJ J Bone Miner Res; 1995 Nov; 10(11):1823-9. PubMed ID: 8592961 [TBL] [Abstract][Full Text] [Related]
20. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. Eriksen EF; Charles P; Melsen F; Mosekilde L; Risteli L; Risteli J J Bone Miner Res; 1993 Feb; 8(2):127-32. PubMed ID: 8442431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]